Fei Liang

4.1k total citations · 1 hit paper
151 papers, 2.4k citations indexed

About

Fei Liang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Fei Liang has authored 151 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 34 papers in Surgery. Recurrent topics in Fei Liang's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). Fei Liang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). Fei Liang collaborates with scholars based in China, United States and United Kingdom. Fei Liang's co-authors include Yongzhi Xi, Weiyao Yan, Mingqiu Liu, Weizao Chen, Zhaoxin Zheng, Wenfeng Li, Nan Liu, Xiao Zhao, Ye Wei and Guodong He and has published in prestigious journals such as JAMA, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Fei Liang

136 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial

2022 237 citations Weitang Yuan, Taiyuan Li et al. profile →

Peers

Countries citing papers authored by Fei Liang

Since Specialization

Citations

This map shows the geographic impact of Fei Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Liang more than expected).

Fields of papers citing papers by Fei Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Liang. The network helps show where Fei Liang may publish in the future.

Co-authorship network of co-authors of Fei Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Liang. A scholar is included among the top collaborators of Fei Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Liang. Fei Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Influence of surgical start time on the quality of surgery for middle and low rectal cancer: a post hoc analysis of the real trial 2025 ·International Journal of Surgery ·Guodong He, (unknown), Weitang Yuan, Taiyuan Li, Bo Tang, Baoqing Jia, Yanbing Zhou, Wei Zhang, Ren Zhao, Cheng Zhang, Longwei Cheng, Xiaoqiao Zhang, Fei Liang, Ye Wei, (unknown), Jianmin Xu	0
2	Cytoreductive surgery and hyperthermic intrathoracic chemotherapy in thymic epithelial tumors with pleural spread or recurrence: a prospective, single-arm, phase II study 2025 ·Nature Communications ·Shuai Wang, (unknown), (unknown), Fei Liang, Yuansheng Zheng, (unknown), (unknown), Hao Wang, Lijie Tan, Jian‐Yong Ding	0
3	A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2‐ breast cancer‐FINEST study 2025 ·Cancer Communications ·Li Chen, Wenya Wu, Fei Liang, Guang‐Yu Liu, Ke‐Da Yu, Jiong Wu, Gen‐Hong Di, Lei Fan, Zhonghua Wang, Junjie Li, Zhi‐Ming Shao	3
4	Cryoablation plus sintilimab and lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial 2025 ·Nature Cancer ·(unknown), (unknown), Yalei Zhang, Ling Qian, Kai Chen, Fei Liang, (unknown), (unknown), Yating Wang, Jingjing Liu, Zhouyu Ning, Litao Xu, Zhiqiang Meng, Li Ye, Peng Wang	0
5	Development of a deep learning-based automatic detection model for gastroesophageal varices using transient elastography 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Fei Liang, Xiaoxiao Chen	0
6	Low-cost single-shot complex optical field imaging with a simplified aperture 2024 ·Optics and Lasers in Engineering ·Ruifeng Zhang, Huayu Li, Yunxu Sun, Fei Liang, (unknown), Chengqing Ning, Xiaochuan Xu, Zhengjun Liu, Wei Liu	0
7	Two stage, multi-center trial of cadonilimab and LM-302 for patients with CLDN18.2+ biliary tract cancer (BTC) that failed chemotherapy and PD-(L)1 antibody (ZSAB-Calm). 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Xiaoyong Huang, Qiang Gao, Fei Liang, Ning Ren, Yongyong Shi, Yong Yi, Zheng Wang, Yiyi Yu, Zhiqiang Hu, (unknown), (unknown), Zhiqiu Hu, (unknown), Zhen Chen	2
8	Neoadjuvant Immunotherapy for Patients With Microsatellite Instability-High or POLE-Mutated Locally Advanced Colorectal Cancer With Bulky Tumors: New Optimization Strategy 2024 ·Clinical Colorectal Cancer ·Yingjie Li, Fei Liang, Zhongwu Li, Xiao Yan Zhang, Aiwen Wu	0
9	Heterogeneity of Radiological Progression Patterns and Association with Outcomes in Patients with Metastatic Prostate Cancer 2023 ·European Urology Oncology ·(unknown), Junlong Wu, Jian Pan, Xiaomeng Li, (unknown), Wei Yu, Dingwei Ye, Fei Liang, Yao Zhu	1
10	Ultrasound lmaging-vulnerable plaque diagnostics: Automatic carotid plaque segmentation based on deep learning 2023 ·SHILAP Revista de lepidopterología ·Xiaoxiao Chen, (unknown), (unknown), Fei Liang, (unknown), Shanshan Wang, (unknown)	7
11	FT-IR combined with PSO-CNN algorithm for rapid screening of cervical tumors 2022 ·Photodiagnosis and Photodynamic Therapy ·Yuhua Ma, Fei Liang, Min Zhu, Cheng Chen, Chen Chen, Xiaoyi Lv	12
12	SORBS2 is a genetic factor contributing to cardiac malformation of 4q deletion syndrome patients 2021 ·eLife ·Fei Liang, (unknown), Juan Geng, (unknown), (unknown), Min Zhang, (unknown), Huiwen Chen, Qihua Fu, Xiaoqing Zhang, Zhen Zhang	11
13	Dual immune checkpoint blockade for non-small cell lung cancer patients with PD-L1 high expression: calling an end? 2021 ·Translational Lung Cancer Research ·Ling Peng, Justin Stebbing, Fei Liang, Yang Xia	2
14	Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer 2019 ·SHILAP Revista de lepidopterología ·Shi Wei, Rui Jiang, Fei Liang, (unknown), (unknown), Jing Zhao	1
15	Lung cancer incidence in female rises significantly in urban sprawl of Shanghai after introduction of LDCT screening 2019 ·Lung Cancer ·Fei Liang, Chunxiao Wu, (unknown), Meiying Zhu, (unknown), Yonggen Jiang, Haiquan Chen, Chen Fu, Ying Zheng	15
16	Vaccination with a Novel Antigen-Specific Tolerizing DNA Vaccine Encoding CCOL2A1 Protects Rats from Experimental Rheumatoid Arthritis 2018 ·Human Gene Therapy ·Xiao Zhao, (unknown), Fei Liang, Nan Liu, (unknown), Yongzhi Xi	8
17	Risk of Pneumonitis Associated with Programmed Cell Death 1 Inhibitors in Cancer Patients: A Meta-analysis 2017 ·Molecular Cancer Therapeutics ·Sheng Zhang, Fei Liang, Ji Zhu, Qiang Chen	18
18	Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines 2008 ·Vaccine ·Xinqiang Song, Fei Liang, Nan Liu, Yuan Luo, (unknown), Yuan Fang, (unknown), (unknown), (unknown), Yongzhi Xi	32
19	RNA Interference Targeting VP1 Inhibits Foot-and-Mouth Disease Virus Replication in BHK-21 Cells and Suckling Mice 2004 ·Journal of Virology ·Weizao Chen, Weiyao Yan, (unknown), Fei Liang, Mingqiu Liu, Zheng Ni, (unknown), Zhaoxin Zheng	106
20	Sp1 Dependence of Natriuretic Peptide Receptor A Gene Transcription in Rat Aortic Smooth Muscle Cells 1999 ·Endocrinology ·Fei Liang	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Closset Breakdown of academic impact, for papers by Rami Mahfouz Breakdown of academic impact, for papers by Bin Zhou Breakdown of academic impact, for papers by Hongbing Liu Breakdown of academic impact, for papers by Irma Virant‐Klun Breakdown of academic impact, for papers by Akira Fuse Breakdown of academic impact, for papers by Kuo-Jang Kao Breakdown of academic impact, for papers by Weiguo Hu